1. 同济大学附属上海市第十人民医院中医科
2. 同济大学中医研究所
纸质出版:2012
移动端阅览
[1]陈丽娟,颜新,韩天雄,王昀,颜乾麟,季蓓,孔令越,王瑱,刘珺,颜琼枝,李露露,颜德馨.温阳活血方治疗急性冠状动脉综合征不稳定型心绞痛42例临床研究[J].中医杂志,2012,53(03):207-211.
CHEN Lijuan1, YAN Xin2, HAN Tianxiong1, et al. Clinical Study on Wenyang Huoxue Formula for Treating 42 Patients with Unstable Angina Pectoris of Acute Coronary Syndrome[J]. Journal of Traditional Chinese Medicine2012, 53(3): 207-211.
[1]陈丽娟,颜新,韩天雄,王昀,颜乾麟,季蓓,孔令越,王瑱,刘珺,颜琼枝,李露露,颜德馨.温阳活血方治疗急性冠状动脉综合征不稳定型心绞痛42例临床研究[J].中医杂志,2012,53(03):207-211. DOI: 10.13288/j.11-2166/r.2012.03.027.
CHEN Lijuan1, YAN Xin2, HAN Tianxiong1, et al. Clinical Study on Wenyang Huoxue Formula for Treating 42 Patients with Unstable Angina Pectoris of Acute Coronary Syndrome[J]. Journal of Traditional Chinese Medicine2012, 53(3): 207-211. DOI: 10.13288/j.11-2166/r.2012.03.027.
目的 观察温阳活血方治疗急性冠状动脉综合征(ACS)不稳定型心绞痛的疗效并探讨其作用机制。方法 将86例ACS不稳定型心绞痛阳虚血瘀证患者随机分为治疗组42例及对照组44例。对照组给予西药常规治疗
治疗组在西药常规治疗的同时加用温阳活血方。观察并记录两组患者治疗前和治疗后1周、2周、3周、4周临床症状、体征、中医证候积分及实验室指标
随访1个月。结果 治疗后两组临床症状水平和症状积分与治疗前比较均明显改善(P<0.05或P<0.01);且治疗组临床疗效优于对照组;治疗后治疗组肌红蛋白水平较治疗前降低(P<0.05);血栓素B2(TXB2)、6-酮-前列腺素F1α(6-keto-PGF1α)水平与治疗前比较改善明显(P<0.05)
且治疗组在降低TXB2水平及升高6-keto-PGF1α方面优于对照组(P<0.05)。治疗过程及随访中
两组患者均未发现心率、心律、血压等的药物性异常变化及血常规、尿常规、肝功能、肾功能的改变(P>0.05)。结论 温阳活血方治疗ACS不稳定型心绞痛安全有效
可明显改善患者的临床症状
其治疗机制可能是通过调节血管内皮功能发挥作用。
Objective To study the effect and mechanism of Wenyang Huoxue Formula (Formula for warming yang and activating blood circulation) on the unstable angina pectoris of acute coronary syndrome (ACS). Methods Eighty-six cases of unstable angina pectoris of ACS in TCM syndrome of yang deficiency with blood stasis were randomized into treatment group
42 cases
and control group
44 cases. Both groups were treated with standard management
and the treatment group was administered Wenyang Huoxue Formula additionally. The clinical symptoms and signs
scores of TCM syndromes and laboratory indexes were observed and recorded before treatment and 1 week
2 weeks
3 weeks
and 4 weeks after treatment
and 1 month’s follow-up was given. Results After treatment
the clinical symptoms and symptom scores of both groups were significantly improved (P<0.05 or P<0.01)
and the clinical curative effect of the treatment group was better than that of the control group. After treatment
the level of myohemoglobin in the treatment group was reduced (P<0.05). The levels of thromboxane B2 (TXB2) and 6-keto-prostaglandin F1α (6-keto-PGF1α) in the treatment group were significantly improved compared with before treatment (P<0.05)
and the improvement of the treatment group was superior (P<0.05). In the duration of treatment and follow-up
there were no drug-induced changes of heart rate and rhythm
blood pressure
abnormal changes in routine blood and urine examinations
and liver and kidney functions of the patients of the two groups. Conclusion Wenyang Huoxue Formula is safe and effective in treating unstable angina pectoris of ACS
and it improves the clinical symptoms significantly. Its therapeutic mechanism is possibly related to the regulation of angioendothelial function.
0
浏览量
366
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号